Amgen Inc Stock Analysis

AMGN Stock  USD 309.41  5.44  1.73%   
Amgen Inc is fairly valued with Real Value of 299.13 and Target Price of 258.8. The main objective of Amgen stock analysis is to determine its intrinsic value, which is an estimate of what Amgen Inc is worth, separate from its market price. There are two main types of Amgen's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Amgen's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Amgen's stock to identify patterns and trends that may indicate its future price movements.
The Amgen stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Amgen is usually not traded on Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Amgen Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Amgen's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

Amgen Stock Analysis Notes

About 81.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 2.39. Amgen Inc recorded earning per share (EPS) of 6.99. The entity last dividend was issued on the 16th of May 2024. The firm had 2:1 split on the 22nd of November 1999. Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California. Amgen operates under Drug ManufacturersGeneral classification in the United States and is traded on NASDAQ Exchange. It employs 24200 people. For more info on Amgen Inc please contact Robert Bradway at 805 447 1000 or go to https://www.amgen.com.

Amgen Quarterly Total Revenue

7.4 Billion

Amgen Inc Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Amgen's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Amgen Inc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Over 81.0% of the company shares are held by institutions such as insurance companies
Latest headline from finance.yahoo.com: Disposition of 2508 shares by Matthew Busch of Amgen at 235.97 subject to Rule 16b-3

Amgen Inc Upcoming and Recent Events

Earnings reports are used by Amgen to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Amgen previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
6th of February 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Amgen Largest EPS Surprises

Earnings surprises can significantly impact Amgen's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
1998-07-22
1998-06-300.180.210.0316 
1999-10-20
1999-09-300.240.280.0416 
2006-07-20
2006-06-300.941.050.1111 
View All Earnings Estimates

Amgen Environmental, Social, and Governance (ESG) Scores

Amgen's ESG score is a quantitative measure that evaluates Amgen's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Amgen's operations that may have significant financial implications and affect Amgen's stock price as well as guide investors towards more socially responsible investments.

Amgen Thematic Classifications

In addition to having Amgen stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Drugs Idea
Drugs
Drug manufacturing and delivery
Health Management Idea
Health Management
Healthcare providers, hospitals
Giant Impact Idea
Giant Impact
Public companies with mega capitalization
Cash Cows Idea
Cash Cows
Companies that have the ability to maintain consistent cash flow over time
Macroaxis Index Idea
Macroaxis Index
Macroaxis power theme of selected equities with solid fundamentals
Macroaxis Picks Idea
Macroaxis Picks
Macroaxis daily picks
Baby Boomer Prospects Idea
Baby Boomer Prospects
Mega stocks, funds and ETFs that tend to appeal to people considering retirement from the work force
Robots And Drones Idea
Robots And Drones
Cross-sector firms and funds that develop or invest in technology that can replicate repetitive human actions

Amgen Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Amgen is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Amgen Inc backward and forwards among themselves. Amgen's institutional investor refers to the entity that pools money to purchase Amgen's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Northern Trust Corp2023-12-31
6.4 M
Royal Bank Of Canada2023-12-31
5.8 M
Bank Of New York Mellon Corp2023-12-31
5.5 M
Norges Bank2023-12-31
5.4 M
Legal & General Group Plc2023-12-31
M
Fmr Inc2023-12-31
4.8 M
Bank Of America Corp2023-12-31
4.3 M
Aristotle Capital Management Llc2023-12-31
4.2 M
Jpmorgan Chase & Co2023-12-31
M
Vanguard Group Inc2023-12-31
49 M
Blackrock Inc2023-12-31
47.8 M
Note, although Amgen's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Amgen Market Capitalization

The company currently falls under 'Mega-Cap' category with a current market capitalization of 168.9 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Amgen's market, we take the total number of its shares issued and multiply it by Amgen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Amgen Profitablity

Amgen's profitability indicators refer to fundamental financial ratios that showcase Amgen's ability to generate income relative to its revenue or operating costs. If, let's say, Amgen is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Amgen's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Amgen's profitability requires more research than a typical breakdown of Amgen's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.13 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.13 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.13.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.15  0.12 
Return On Capital Employed 0.10  0.1 
Return On Assets 0.07  0.12 
Return On Equity 1.08  1.13 

Management Efficiency

Amgen Inc has return on total asset (ROA) of 0.0488 % which means that it generated a profit of $0.0488 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.7257 %, meaning that it created $0.7257 on every $100 dollars invested by stockholders. Amgen's management efficiency ratios could be used to measure how well Amgen manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Amgen's Return On Assets are very stable compared to the past year. As of the 23rd of May 2024, Return On Equity is likely to grow to 1.13, while Return On Tangible Assets are likely to drop 0.12. At this time, Amgen's Return On Assets are very stable compared to the past year. As of the 23rd of May 2024, Asset Turnover is likely to grow to 0.51, while Other Current Assets are likely to drop about 266.9 M.
Last ReportedProjected for Next Year
Book Value Per Share 11.65  10.26 
Net Current Asset Value 0.00  0.00 
Tangible Asset Value 0.00  0.00 
Tangible Book Value Per Share(84.18)(79.97)
Enterprise Value Over EBITDA 14.04  11.29 
Price Book Value Ratio 24.73  25.96 
Enterprise Value Multiple 14.04  11.29 
Price Fair Value 24.73  25.96 
Enterprise Value51.4 B53.9 B
The analysis of Amgen's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Amgen's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Amgen Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Dividend Yield
0.0286
Forward Dividend Yield
0.0286
Forward Dividend Rate
9
Beta
0.599

Technical Drivers

As of the 23rd of May, Amgen shows the risk adjusted performance of 0.0549, and Mean Deviation of 1.17. Amgen Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Amgen Inc, which can be compared to its peers. Please confirm Amgen Inc treynor ratio, and the relationship between the standard deviation and downside variance to decide if Amgen Inc is priced correctly, providing market reflects its regular price of 309.41 per share. Given that Amgen has jensen alpha of 0.0708, we suggest you to validate Amgen Inc's prevailing market performance to make sure the company can sustain itself at a future point.

Amgen Inc Price Movement Analysis

Execute Study
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Amgen middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Amgen Inc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Amgen Inc Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Amgen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Amgen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Amgen insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Amgen Outstanding Bonds

Amgen issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Amgen Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Amgen bonds can be classified according to their maturity, which is the date when Amgen Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Amgen Predictive Daily Indicators

Amgen intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Amgen stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Amgen Corporate Filings

10th of May 2024
Other Reports
ViewVerify
F4
9th of May 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
8th of May 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
7th of May 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
6th of May 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
10Q
3rd of May 2024
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify
8K
2nd of May 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
1st of May 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify

Amgen Forecast Models

Amgen's time-series forecasting models are one of many Amgen's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Amgen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Amgen Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Amgen prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Amgen shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Amgen. By using and applying Amgen Stock analysis, traders can create a robust methodology for identifying Amgen entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.28  0.25 
Operating Profit Margin 0.28  0.26 
Net Profit Margin 0.24  0.18 
Gross Profit Margin 0.70  0.65 

Current Amgen Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Amgen analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Amgen analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
258.8Buy29Odds
Amgen Inc current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Amgen analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Amgen stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Amgen Inc, talking to its executives and customers, or listening to Amgen conference calls.
Amgen Analyst Advice Details

Amgen Stock Analysis Indicators

Amgen Inc stock analysis indicators help investors evaluate how Amgen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Amgen shares will generate the highest return on investment. By understating and applying Amgen stock analysis, traders can identify Amgen position entry and exit signals to maximize returns.
Begin Period Cash Flow7.6 B
Long Term Debt63.2 B
Common Stock Shares Outstanding538 M
Total Stockholder Equity6.2 B
Total Cashflows From Investing Activities-26.2 B
Tax Provision1.2 B
Quarterly Earnings Growth Y O Y-0.524
Property Plant And Equipment Net5.9 B
Cash And Short Term Investments10.9 B
Cash10.9 B
Accounts Payable1.6 B
Net Debt53.7 B
50 Day M A282.7524
Total Current Liabilities18.4 B
Other Operating Expenses20.3 B
Non Current Assets Total66.8 B
Forward Price Earnings13.7741
Non Currrent Assets Other9.6 B
Stock Based Compensation431 M
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Note that the Amgen Inc information on this page should be used as a complementary analysis to other Amgen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for Amgen Stock analysis

When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Fundamental Analysis
View fundamental data based on most recent published financial statements
Is Amgen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amgen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.52)
Dividend Share
8.64
Earnings Share
6.99
Revenue Per Share
55.148
Quarterly Revenue Growth
0.22
The market value of Amgen Inc is measured differently than its book value, which is the value of Amgen that is recorded on the company's balance sheet. Investors also form their own opinion of Amgen's value that differs from its market value or its book value, called intrinsic value, which is Amgen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amgen's market value can be influenced by many factors that don't directly affect Amgen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amgen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amgen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amgen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.